PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsSulfamerazine
Sulfamerazine
Lantrisul, Neotrizine, Sulfaloid, Sulfonamides Duplex, Sulfose, Terfonyl, Triple (sulfamerazine) is a small molecule pharmaceutical. Sulfamerazine was first approved as Sulfonamides duplex on 1982-01-01.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Sulfadiazine
+
Sulfamerazine
Tradename
Company
Number
Date
Products
SULFONAMIDES DUPLEXEli LillyN-006317 DISCN1982-01-01
1 products
Hide discontinued
Sulfamerazine
+
Sulfamethazine)
+
Trisulfapyrimidines (sulfadiazine
Tradename
Company
Number
Date
Products
TERFONYLBristol Myers SquibbN-006904 DISCN1982-01-01
2 products
TRIPLE SULFASLederle LaboratoriesN-006920 DISCN1982-01-01
2 products
NEOTRIZINEEli LillyN-006317 DISCN1982-01-01
2 products
Hide discontinued
Sulfacetamide
+
Sulfathiazole)
+
Triple sulfa (sulfabenzamide
Tradename
Company
Number
Date
Products
SULTRINJohnson & JohnsonN-005794 DISCN1982-01-01
2 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
corneal ulcer—D003320H16.0
bacterial infections—D001424A49
bacterial skin diseases—D017192—
trachoma—D014141A71
ear diseasesEFO_1001455D004427H93.9
seborrheic dermatitisHP_0001051D012628L21
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
— D06: Antibiotics and chemotherapeutics for dermatological use
— D06B: Chemotherapeutics for topical use
— D06BA: Sulfonamides, topical
— D06BA06: Sulfamerazine
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01E: Sulfonamides and trimethoprim antibacterials for systemic use
— J01ED: Long-acting sulfonamides
— J01ED07: Sulfamerazine
— J01EE: Combinations of sulfonamides and trimethoprim, incl. derivatives
— J01EE07: Sulfamerazine and trimethoprim
HCPCS
No data
Clinical
No data
Drug
General
Drug common nameSulfamerazine
INNsulfamerazine
Description
Sulfamerazine is a sulfonamide consisting of pyrimidine with a methyl substituent at the 4-position and a 4-aminobenzenesulfonamido group at the 2-position. It has a role as an antiinfective agent and a drug allergen. It is a member of pyrimidines, a sulfonamide and a sulfonamide antibiotic. It is functionally related to a sulfanilamide.
Classification
Small molecule
Drug classantimicrobials (sulfonamides derivatives)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1
Identifiers
PDB—
CAS-ID127-79-7
RxCUI—
ChEMBL IDCHEMBL438
ChEBI ID102130
PubChem CID5325
DrugBankDB01581
UNII IDUR1SAB295F (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,316 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
61 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use